Cargando...
Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.
Guardado en:
| Publicado en: | Int Immunopharmacol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8206577/ https://ncbi.nlm.nih.gov/pubmed/34183274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107878 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|